These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 30211270)

  • 1. Data for serum 1,5 anhydroglucitol concentration in different populations.
    Welter M; Boritza KC; Anghebem-Oliveira MI; Henneberg R; Hauser AB; Rego FGM; Picheth G
    Data Brief; 2018 Oct; 20():753-760. PubMed ID: 30211270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference intervals for serum 1,5-anhydroglucitol in children, adolescents, adults, and pregnant women.
    Welter M; Boritza KC; Anghebem-Oliveira MI; Henneberg R; Hauser AB; Rego FGM; Picheth G
    Clin Chim Acta; 2018 Nov; 486():54-58. PubMed ID: 30017617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,5-Anhydroglucitol Concentration as a Biomarker for Type 1 Diabetes in Adults and Children.
    Martins BR; Gomes LC; Boritza KC; Anghebem-Oliveira MI; Souza EM; França SN; Picheth G; Rego FGM
    Clin Lab; 2019 Sep; 65(9):. PubMed ID: 31532108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 1,5-anhydro-d-glucitol in clinical and forensic urine samples.
    Sydow K; Wiedfeld C; Musshoff F; Madea B; Tschoepe D; Stratmann B; Hess C
    Forensic Sci Int; 2018 Jun; 287():88-97. PubMed ID: 29655100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and forensic examinations of glycemic marker 1,5-anhydroglucitol by means of high performance liquid chromatography tandem mass spectrometry.
    Hess C; Stratmann B; Quester W; Madea B; Musshoff F; Tschoepe D
    Forensic Sci Int; 2012 Oct; 222(1-3):132-6. PubMed ID: 22749674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
    Won JC; Park CY; Park HS; Kim JH; Choi ES; Rhee EJ; Lee WY; Oh KW; Kim SW; Park SW
    Diabetes Res Clin Pract; 2009 Apr; 84(1):51-7. PubMed ID: 19187997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.
    Pramodkumar TA; Jayashri R; Gokulakrishnan K; Velmurugan K; Pradeepa R; Anjana RM; Mohan V
    Indian J Endocrinol Metab; 2016; 20(5):690-695. PubMed ID: 27730082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes.
    Yoo HY; Kwak BO; Son JS; Kim KS; Chung S
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):192-7. PubMed ID: 26817006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close relationship between serum concentrations of 1,5-anhydroglucitol and uric acid in non-diabetic male subjects implies common renal transport system.
    Koga M; Murai J; Saito H; Mukai M; Kasayama S; Moriwaki Y; Yamamoto T
    Clin Chim Acta; 2009 Dec; 410(1-2):70-3. PubMed ID: 19781540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y; Yang R; Song Y; Wang Y
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of an assay for serum 1,5-anhydroglucitol (GlycoMark) and determination of reference intervals on the Hitachi 917 analyzer.
    Nowatzke W; Sarno MJ; Birch NC; Stickle DF; Eden T; Cole TG
    Clin Chim Acta; 2004 Dec; 350(1-2):201-9. PubMed ID: 15530479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.
    Malkan UY; Gunes G; Corakci A
    Springerplus; 2015; 4():587. PubMed ID: 26543722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between baseline serum 1,5-anhydroglucitol levels and 2-hour post-challenge glucose levels during oral glucose tolerance tests.
    Goto M; Yamamoto-Honda R; Shimbo T; Goto A; Terauchi Y; Kanazawa Y; Noda M
    Endocr J; 2011; 58(1):13-7. PubMed ID: 21084770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
    Stickle D; Turk J
    Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus.
    Ouchi M; Oba K; Ohara M; Igari Y; Futami-Suda S; Ishii K; Aoyama J; Onishi T; Tsunoda-Kubota M; Yamashita H; Suzuki T; Nakano H
    Clin Chim Acta; 2014 Jun; 433():88-92. PubMed ID: 24326128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.